2 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid TumorsAdvanced Solid TumorRecruitingPhase 12026-09-11NCT06598800
Tislelizumab (Anti-Programmed Cell Death Protein-1 (PD-1) Antibody) in MSI-H or dMMR Solid TumorsMSI-H/dMMR Solid TumorsRecruitingPhase 22026-07-10NCT03736889